Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Phase Holographic Imaging PHI AB's enterprise value is €1.58 Mil.
Phase Holographic Imaging PHI AB's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 was €-1.54 Mil. Therefore, Phase Holographic Imaging PHI AB's EV-to-EBITDA for today is -1.03.
The historical rank and industry rank for Phase Holographic Imaging PHI AB's EV-to-EBITDA or its related term are showing as below:
FRA:L5W'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -121.67 Med: -21 Max: -1.08
Current: -1.23
During the past 13 years, the highest EV-to-EBITDA of Phase Holographic Imaging PHI AB was -1.08. The lowest was -121.67. And the median was -21.00.
FRA:L5W's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 14.59
vs FRA:L5W: -1.23
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Phase Holographic Imaging PHI AB (FRA:L5W) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Phase Holographic Imaging PHI AB's PE Ratio (TTM) for today is calculated as:
Phase Holographic Imaging PHI AB's share price for today is €0.0436.
Phase Holographic Imaging PHI AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.038.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB EV-to-EBITDA Chart
For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phase Holographic Imaging PHI AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Phase Holographic Imaging PHI AB's EV-to-EBITDA falls into.
Phase Holographic Imaging PHI AB's current Enterprise Value is €1.58 Mil.
Phase Holographic Imaging PHI AB's EBITDA for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phase Holographic Imaging PHI AB (FRA:L5W) has a EV-to-EBITDA of -1.03 as of Aug. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Phase Holographic Imaging PHI AB.
Is Phase Holographic Imaging PHI AB's EV-to-EBITDA too high?
Phase Holographic Imaging PHI AB's current EV-to-EBITDA is -1.03.
How does Phase Holographic Imaging PHI AB's EV-to-EBITDA compare to ABT and BSX?
Phase Holographic Imaging PHI AB's EV-to-EBITDA of -1.03 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.59, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Phase Holographic Imaging PHI AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current EV-to-EBITDA is -1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current EV-to-EBITDA of -1.03. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current EV-to-EBITDA is -1.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current EV-to-EBITDA is -1.03 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L5W has been successfully added to your 
